Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 3 years ago Source:  Veryan Medical and Otsuka Medical Devices
TOKYO, Japan and HORSHAM, U.K., 13 December, 2018 — Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical Ltd. (“Veryan”) announce the completion of the acquisition of Veryan by Otsuka Medical Devices through its UK subsidiary Otsuka Medical Devices UK Ltd. Veryan’s BioMimics 3D peripheral vascular stent received U.S. FDA… View more
Author(s): Marcus Bracklo , Ulrike Marczak Added: 3 years ago
The recent acquisitions of two leading American reprocessing businesses by leading medical devices manufacturers have relaunched the debate around the reprocessing of medical devices. In 2009, Stryker acquired Ascent and, more recently, Johnson & Johnson acquired SterilMed. This represents a major shift in the strategy of large medical devices companies. In the past, they were very critical of… View more

Electrophysiology & Arrhythmia
Vanguard AG

Supplier

As an innovative technology partner, VANGUARD supports hospitals with sustainable solutions providing improved quality and efficiency. VANGUARD is a manufacturer of medical devices and market leader in the validated special reprocessing of complex medical devices in Europe. In addition, the company is the German market leader in the field of all round system solutions for the supply of sterile… View more
Author(s): HF Pitschner , P Reinesch , H Bahavar , et al Added: 3 years ago
Since 1996 our electrophysiological diagnostic catheters and ablation catheters have been submitted to a certified (DIN EN ISO 13485) reprocessing company (Remed GmbH®, a member of the VANGUARD group). Each step of reprocessing that the catheters have to pass is certified according to the existing international regulations (standards, guidelines, etc.), which is required by law in Germany1,2 and… View more

Digital Health
Added: 3 years ago Source:  Biosense Webster, Inc.
Irvine, California – February 4, 2019 – Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study** which evaluates the company’s QDOT MICRO Radiofrequency (RF) Ablation Catheter used for the… View more
Job title: CEO and Co-Founder of Conformal Medical, Inc
Andy is an entrepreneur with over thirty-five years of engineering, marketing and general business experience developing medical devices and starting companies. Andy is CEO and Co-founder of Conformal Medical, Inc., a clinical stage company developing Left Atrial Appendage closure technologies. He previously held a position in Business Development for medical devices at Harvard’s Wyss… View more